News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shionogi, Inc.-ViiV Healthcare to File HIV Drug dolutegravir for Approval


10/4/2012 7:27:29 AM

GlaxoSmithKline PLC (GSK.LN), a pharmaceutical company, said Thursday that Shionogi-ViiV Healthcare LLC has completed the initial clinical registration package for dolutegravir in HIV. MAIN FACTS: -Shionogi-ViiV Healthcare LLC, a joint venture between ViiV Healthcare Ltd (a global specialist HIV company established by GlaxoSmithKline and Pfizer, Inc.) and Shionogi & Co., Ltd, said that the phase III data required for initial regulatory filings of the investigational integrase inhibitor dolutegravir in adults infected with HIV are in house.

Read at Nasdaq
Read at Share Cast
Read at News Release
Read at News Release


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES